PFIZER INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Pfizer Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2010 to Q3 2024.
  • Pfizer Inc Net Income (Loss) Attributable to Parent for the quarter ending September 29, 2024 was $4.47B.
  • Pfizer Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 29, 2024 was $4.25B, a 59.4% decline year-over-year.
  • Pfizer Inc annual Net Income (Loss) Attributable to Parent for 2023 was $2.12B, a 93.2% decline from 2022.
  • Pfizer Inc annual Net Income (Loss) Attributable to Parent for 2022 was $31.4B, a 42.7% increase from 2021.
  • Pfizer Inc annual Net Income (Loss) Attributable to Parent for 2021 was $22B, a 140% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $4.25B $4.47B +$6.85B Jul 1, 2024 Sep 29, 2024 10-Q 2024-11-04
Q2 2024 -$2.6B $41M -$2.29B -98.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 -$309M $3.12B -$2.43B -43.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $2.12B -$3.37B -$8.36B -167% Oct 2, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $10.5B -$2.38B -$11B -128% Jul 3, 2023 Oct 1, 2023 10-Q 2024-11-04
Q2 2023 $21.5B $2.33B -$7.58B -76.5% Apr 3, 2023 Jul 2, 2023 10-Q 2024-08-05
Q1 2023 $29.1B $5.54B -$2.32B -29.5% Jan 1, 2023 Apr 2, 2023 10-Q 2024-05-08
Q4 2022 $31.4B $4.99B +$1.6B +47.2% Oct 3, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $29.8B $8.61B +$462M +5.67% Jul 4, 2022 Oct 2, 2022 10-Q 2023-11-08
Q2 2022 $29.3B $9.91B +$4.34B +78.1% Apr 4, 2022 Jul 3, 2022 10-Q 2023-08-09
Q1 2022 $25B $7.86B +$2.99B +61.2% Jan 1, 2022 Apr 3, 2022 10-Q 2023-05-10
Q4 2021 $22B $3.39B +$2.55B +301% Oct 4, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $19.4B $8.15B +$6.68B +455% Jul 5, 2021 Oct 3, 2021 10-Q 2022-11-09
Q2 2021 $12.8B $5.56B +$2.07B +59.4% Apr 5, 2021 Jul 4, 2021 10-Q 2022-08-10
Q1 2021 $10.7B $4.88B +$1.52B +45.4% Jan 1, 2021 Apr 4, 2021 10-Q 2022-05-11
Q4 2020 $9.16B $846M +$1.43B Sep 28, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $7.73B $1.47B -$6.21B -80.9% Jun 29, 2020 Sep 27, 2020 10-Q 2021-11-12
Q2 2020 $13.9B $3.49B -$1.56B -30.9% Mar 30, 2020 Jun 28, 2020 10-Q 2021-08-12
Q1 2020 $15.5B $3.36B -$529M -13.6% Jan 1, 2020 Mar 29, 2020 10-Q 2021-05-13
Q4 2019 $16B -$584M -$190M -48.2% Sep 30, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $16.2B $7.68B +$3.57B +86.7% Jul 1, 2019 Sep 29, 2019 10-Q 2020-11-05
Q2 2019 $12.7B $5.05B +$1.17B +30.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $11.5B $3.88B +$323M +9.07% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $11.2B -$394M -$12.7B -103% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $23.8B $4.11B +$1.27B +44.9% Jul 2, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $22.5B $3.87B +$799M +26% Apr 2, 2018 Jul 1, 2018 10-Q 2019-08-08
Q1 2018 $21.7B $3.56B +$440M +14.1% Jan 1, 2018 Apr 1, 2018 10-Q 2019-05-09
Q4 2017 $21.3B $12.3B +$11.5B +1484% Oct 2, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $9.81B $2.84B +$1.49B +110% Jul 3, 2017 Oct 1, 2017 10-Q 2018-11-08
Q2 2017 $8.32B $3.07B +$1.03B +50.1% Apr 3, 2017 Jul 2, 2017 10-Q 2018-08-09
Q1 2017 $7.3B $3.12B +$83M +2.73% Jan 1, 2017 Apr 2, 2017 10-Q 2018-05-10
Q4 2016 $7.22B $775M +$947M Oct 3, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $6.27B $1.36B -$775M -36.4% Jul 4, 2016 Oct 2, 2016 10-Q 2017-11-09
Q2 2016 $7.04B $2.05B -$579M -22% Apr 4, 2016 Jul 3, 2016 10-Q 2017-08-10
Q1 2016 $7.62B $3.04B +$662M +27.9% Jan 1, 2016 Apr 3, 2016 10-Q 2017-05-11
Q4 2015 $6.96B -$172M -$1.4B -114% Sep 28, 2015 Dec 31, 2015 10-K 2018-02-22
Q3 2015 $8.36B $2.13B -$536M -20.1% Jun 29, 2015 Sep 27, 2015 10-Q 2016-11-10
Q2 2015 $8.9B $2.63B -$286M -9.82% Mar 30, 2015 Jun 28, 2015 10-Q 2016-08-11
Q1 2015 $9.18B $2.38B +$47M +2.02% Jan 1, 2015 Mar 29, 2015 10-Q 2016-05-12
Q4 2014 $9.14B $1.23B -$1.34B -52.2% Sep 29, 2014 Dec 31, 2014 10-K 2017-02-23
Q3 2014 $10.5B $2.67B +$76M +2.93% Jun 30, 2014 Sep 28, 2014 10-Q 2015-11-05
Q2 2014 $10.4B $2.91B -$11.2B -79.3% Mar 31, 2014 Jun 29, 2014 10-Q 2015-08-06
Q1 2014 $21.6B $2.33B -$421M -15.3% Jan 1, 2014 Mar 30, 2014 10-Q 2015-05-07
Q4 2013 $22B $2.57B -$3.75B -59.3% Sep 30, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $25.8B $2.59B -$618M -19.3% Jul 1, 2013 Sep 29, 2013 10-Q 2014-11-06
Q2 2013 $26.4B $14.1B +$10.8B +333% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $15.5B $2.75B +$956M +53.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $14.6B $6.32B +$4.88B +339% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 $9.69B $3.21B -$530M -14.2% Jul 2, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $10.2B $3.25B +$643M +24.6% Apr 2, 2012 Jul 1, 2012 10-Q 2013-08-09
Q1 2012 $9.58B $1.79B -$428M -19.3% Jan 1, 2012 Apr 1, 2012 10-Q 2013-05-10
Q4 2011 $10B $1.44B -$1.45B -50.2% Oct 3, 2011 Dec 31, 2011 10-K 2014-02-28
Q3 2011 $11.5B $3.74B +$2.87B +332% Jul 4, 2011 Oct 2, 2011 10-Q 2012-11-09
Q2 2011 $8.59B $2.61B +$135M +5.46% Apr 4, 2011 Jul 3, 2011 10-Q 2011-08-11
Q1 2011 $8.45B $2.22B +$196M +9.67% Jan 1, 2011 Apr 3, 2011 10-Q 2012-05-10
Q4 2010 $8.26B $2.89B Oct 4, 2010 Dec 31, 2010 10-K 2013-02-28
Q3 2010 $866M Jul 5, 2010 Oct 3, 2010 10-Q 2011-11-10
Q2 2010 $2.48B Apr 5, 2010 Jul 4, 2010 10-Q 2011-08-11
Q1 2010 $2.03B Jan 1, 2010 Apr 4, 2010 10-Q 2011-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.